The present dosimetric analysis shows that biological half-life, subcellular localization, and the proper account of low-energy electrons is critical in assessing the energy deposition inside the targeted cells from the three iodide radioisotopes examined. From a dosimetric point of view and under the present approximations (123)I might be superior to the other two radioiodides in the treatment of microscopic disease in B-cell lymphoma patients.